The Pharmacy Society of Wisconsin announced resources to assist pharmacists to comply with the new law requiring pseudoephedrine products be tracked electronically through the National Precursor Log Exchange (NPLEx) effective Friday, June 1. PSW created a guide to the law and a training guide for using the internet portal.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
On February 7, 2018, the Board of Pharmacy proposed a change to rule 64B16-27.630 to add Meningococcal B (MedB) and Zoster Vaccine Recombinant, Adjuvanted. The final rule is effective Thursday, April 12, 2018.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
In the wake of new counties being added to the Medicaid Managed Care program (HealthChoice Illinois) effective April 1, the Illinois Pharmacists Association (IPhA) is in regular contact with the Department of Health and Family Services about challenges with patient transitions from fee-for-service to managed care. IPhA indicates that pharmacies having unresolved issues with Medicaid recipients can email IPhA. Please include the Recipient Identification Number (RIN), which MCO (not PBM) and any relevant notes. To file a complaint so that it is on the record, visit the HFS webpage and complete Illinois’ Medicaid Managed Care Organization (MCO) Provider Complaint Form. IPhA also encourages Medicaid recipients who need to enroll or call HealthChoice Illinois with questions to call 877-912-8880 (TTY: 1-866-565-8576) Monday to Friday from 8:00 AM to 7:00 PM.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
The Board of Pharmacy announced, effective Wednesday, May 16, that dispensers will be required to report to the Prescription Monitoring Program by the next business day following dispensing. Questions can be directed to Jennifer Tiffany at 515-242-5139.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
Gov. Jeff Colyer (R) signed into law SB 351, the Kansas Pharmacy Patients Fair Practices Act. The new law states that a pharmacy or pharmacist shall have the right to cost transparency and pricing transparency, and that a pharmacist may discuss lower-cost prescription alternatives with a consumer.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Gov. Rick Snyder (R) signed HB 5678 into law on April 2 with immediate effect, delaying implementation of last year’s legislation that stated, beginning March 31, 2018, a prescriber must not prescribe a Schedule II through V controlled substance unless the prescriber is in a bona fide prescriber-patient relationship with the patient. Under this law, the Department of Health and Human Services (DHHS) is required to promulgate rules defining what constitutes a “bona fide prescriber-patient relationship.” Per HB 5678, the implementation date is now Sunday, March 31, 2019. However, if rules are promulgated by DHHS before that date, the effective date will be the date in which the rules are finalized.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
On April 4, the Department of Insurance issued Bulletin 2018-02, prohibiting insurers and Pharmacy Benefit Managers from:
The bulletin was effective upon release.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Board of Pharmacy has put the newest version of its Pharmacy Law Bookon its website.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
SB 575, legislation allowing pharmacists to substitute interchangeable biologic drugs and establishing guidelines for notification, has been signed by Gov. Scott Walker (R) with an effective date of March 30. For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
Also in Wisconsin… Gov. Walker signed into law AB 681, which will require minors to have a prescription to purchase products containing dextromethorphan, effective Monday, April 1, 2019.
Also in Wisconsin… the Pharmacy Examining Board announced its adopted rules updating standards for sterile and nonsterile compounding to align with USP Chapters <795> and <797> effective Thursday, November 1, 2018.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.